Dongsung Pharm (002210) — Capital Reinvestment Ratio
Dongsung Pharm (002210) has a Capital Reinvestment Ratio of 0.54x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩3.01 Billion) in capital expenditures (₩1.62 Billion). See Dongsung Pharm net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dongsung Pharm Capital Reinvestment Ratio (2010–2020)
This chart tracks Dongsung Pharm's Capital Reinvestment Ratio across 4 annual periods. Check Dongsung Pharm (002210) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dongsung Pharm (2010–2020)
Year-by-year Capital Reinvestment Ratio for Dongsung Pharm from 2010 to 2020. For live market cap and broader valuation context, see Dongsung Pharm market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.38x | ₩5.01 Billion | ₩6.92 Billion | ▼ -9.5% |
| 2018 | 1.53x | ₩1.39 Billion | ₩2.13 Billion | ▼ -8.6% |
| 2017 | 1.67x | ₩1.80 Billion | ₩3.00 Billion | ▲ +626.3% |
| 2010 | 0.23x | ₩3.68 Billion | ₩847.33 Million | — |